株式会社カルディオインテリジェンス
Tokyo, JP · 2 known investors
Cardio Intelligence develops AI-based electrocardiogram analysis software as medical device programs, including its SmartRobin AI long-term ECG analysis series and SmartPAFin software for detecting signs of paroxysmal atrial fibrillation. The company is a licensed medical device manufacturer and distributor based in Tokyo, Japan.
Founders & leadership
YT
Yuichi Tamura代表取締役 (Representative Director / President)
SS
Shigemasa Sasaki取締役CEO (Director & CEO)
MT
Mineki Takechi取締役CDO (Director & CDO)
Investors · 2
Frequently asked questions
- What does 株式会社カルディオインテリジェンス do?
- Cardio Intelligence develops AI-based electrocardiogram analysis software as medical device programs, including its SmartRobin AI long-term ECG analysis series and SmartPAFin software for detecting signs of paroxysmal atrial fibrillation. The company is a licensed medical device manufacturer and distributor based in Tokyo, Japan.
- Who are 株式会社カルディオインテリジェンス's investors?
- 株式会社カルディオインテリジェンス's investors include Samurai Incubate, Shizuoka Capital.
- Where is 株式会社カルディオインテリジェンス headquartered?
- 株式会社カルディオインテリジェンス is headquartered in Tokyo, JP.